T - Lifshitz Law PLLC Announces Investigations of Rain Oncology Inc. (NASDAQ: RAIN) Danaher Corp. (NYSE: DHR) Bausch Health Companies Inc. (NYSE: BHC) and AT&T Inc. (NYSE: T) | Benzinga

NEW YORK, Sept. 02, 2023 (GLOBE NEWSWIRE) --

Rain Oncology, Inc. (NASDAQ:RAIN)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) the Company concealed risks inherent in the design of its Phase 3 MANTRA study particularly with regard to proceeding directly to Phase 3 from Phase 1; and, (ii) as a result, the Company's statements about the trial and the likelihood of FDA approval were materially misleading during the Relevant Period.

If you are a RAIN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

Danaher Corp. (NYSE:DHR)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) as the severity of the COVID-19 pandemic subsided, revenue growth associated with Danaher's COVID-19-related businesses was declining; (ii) contrary to ...

T)>Full story available on Benzinga.com